High-fat diet exacerbates inflammation and cell survival signals in the skin of ultraviolet B-irradiated C57BL/6 mice

Toxicology and Applied Pharmacology

Volumn 241, Issue 3, 2009, Pages 303-310

  Meeran, Syed M ^b   Singh, Tripti ^b   Nagy, Tim R ^b   Katiyar, Santosh K ^a,b  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cyclooxygenase 2; High fat diet; Inflammation; Interleukin; Skin; Ultraviolet radiation

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; CYCLINE; CYCLOOXYGENASE 2; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROTEIN KINASE B; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CANCER RISK; CELL SURVIVAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; LIPID DIET; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN BLOOD LEVEL; RADIATION EXPOSURE; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SKIN CANCER; SKIN DISEASE; SKIN INFLAMMATION; ULTRAVIOLET B RADIATION; WESTERN BLOTTING;

ADIPONECTIN; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CELL SURVIVAL; CYCLOOXYGENASE 2; DIET; DIETARY FATS; DINOPROSTONE; FEMALE; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; ONCOGENE PROTEIN V-AKT; PEROXIDASE; PHOSPHATIDYLINOSITOL 3-KINASES; SKIN; ULTRAVIOLET RAYS; WEIGHT GAIN;

MUS;

EID: 70350599525     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.09.003     Document Type: Article

References (45)

1. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., and Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257 (1999) 79-83
2. Birt D.F., White L.T., Choi B., and Pelling J.C. Dietary fat effects on the initiation and promotion of two-stage skin tumorigenesis in the SENCAR mouse. Cancer Res. 49 (1989) 4170-4174
3. Black H.S. Can diet prevent nonmelanoma skin cancer progression?. Expert Rev. Anticancer Ther. 5 (2005) 801-808
4. Black A.K., Greaves M.W., Hensby C.N., and Plummer N.A. Increased prostaglandins E2 and F2alpha in human skin at 6 and 24 h after ultraviolet B irradiation (290-320 nm). Br. J. Clin. Pharmacol. 5 (1978) 431-436
5. Bradley P.P., Priebat D.A., Christensen R.D., and Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78 (1982) 206-209
6. Bråkenhielm E., Veitonmäki N., Cao R., Kihara S., Matsuzawa Y., Zhivotovsky B., Funahashi T., and Cao Y. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2476-2481
7. Callejas N.A., Casado M., Bosca L., and Martin-Sanz P. Requirement of nuclear factor kappaB for the constitutive expression of nitric oxide synthase-2 and cyclooxygenase-2 in rat trophoblasts. J. Cell Sci. 18 (1999) 3147-3155
8. Carpenter C.L., and Cantley L.C. Phosphoinositide kinases. Curr. Opin. Cell Biol. 8 (1996) 153-158
9. Chapple K.S., Cartwright E.J., Hawcroft G., Tisbury A., Bonifer C., Scott N., Windsor A.C., Guillou P.J., Markham A.F., Coletta P.L., and Hull M.A. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am. J. Pathol. 156 (2000) 545-553
10. Chun K.S., Akunda J.K., and Langenbach R. Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4. Cancer Res. 67 (2007) 2015-2021
11. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10 (1998) 262-267
12. Flegal K.M., Carroll M.D., Ogden C.L., and Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
13. Flegal K.M., Graubard B.I., Williamson D.F., and Gail M.H. Excess deaths associated with underweight, overweight, and obesity. JAMA 293 (2005) 1861-1867
14. Hedley A.A., Ogden C.L., Johnson C.L., Carroll M.D., Curtin L.R., and Flegal K.M. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291 (2004) 2847-2850
15. Katiyar S.K. Treatment of silymarin, a plant flavonoid, prevents ultraviolet light-induced immune suppression and oxidative stress in mouse skin. Int. J. Oncol. 21 (2002) 1213-1222
16. Katiyar S.K. Oxidative stress and photocarcinogenesis: Strategies for prevention. In: Singh K.K. (Ed). Oxidative Stress, Disease and Cancer (2006), Imperial College Press, London 933-964
17. Katiyar S.K., and Meeran S.M. Obesity increases the risk of UV radiation-induced oxidative stress and activation of MAPK and NF-κB signaling. Free Radic. Biol. Med. 42 (2007) 299-310
18. Katiyar S.K., Challa A., McCormick T.S., Cooper K.D., and Mukhtar H. Prevention of UVB-induced immunosuppression in mice by green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogenesis 20 (1999) 2117-2124
19. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89 (2004) 2548-2556
20. Kubota N., Terauchi Y., Yamauchi T., Kubota T., Moroi M., Matsui J., Eto K., Yamashita T., Kamon J., Satoh H., Yano W., Froguel P., Nagai R., Kimura S., Kadowaki T., and Noda T. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem. 277 (2002) 25863-25866
21. Langenbach R., Loftin C.D., Lee C., and Tiano H. Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis. Ann. N. Y. Acad. Sci. 889 (1999) 52-61
22. Lu S., Yu G., Zhu Y., and Archer M.C. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int. J. Cancer 116 (2005) 847-852
23. Luo J., Manning B.D., and Cantley L.C. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4 (2003) 257-262
24. Marks F., Fürstenberger G., and Müller-Decker K. Metabolic targets of cancer chemoprevention: interruption of tumor development by inhibitors of arachidonic acid metabolism. Recent Results Cancer Res. 151 (1999) 45-67
25. Meeran S.M., Punathil T., and Katiyar S.K. Interleukin-12-deficiency exacerbates inflammatory responses in UV-irradiated skin and skin tumors. J. Invest. Dermatol. 128 (2008) 2716-2727
26. Meeran S.M., Akhtar S., and Katiyar S.K. Inhibition of UVB-induced skin tumor development by drinking green tea polyphenols is mediated through DNA repair and subsequent inhibition of inflammation. J. Invest. Dermatol. 129 (2009) 1258-1270
27. Mills G.B., Kohn E., Lu Y., Eder A., Fang X., Wang H., Bast R.C., Gray J., Jaffe R., and Hortobagyi G. Linking molecular diagnostics to molecular therapeutics: targeting the PI3K pathway in breast cancer. Semin. Oncol. 30 (2003) 93-104
28. Mukherjee P., Sotnikov A.V., Mangian H.J., Zhou J.R., Visek W.J., and Clinton S.K. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. J. Natl. Cancer Inst. 91 (1999) 512-523
29. Mukhtar H., and Elmets C.A. Photocarcinogenesis: mechanisms, models and human health implications. Photochem. Photobiol. 63 (1996) 355-447
30. Nomura M., Kaji A., Ma W.Y., Zhong S., Liu G., Bowden G.T., Miyamoto K.I., and Dong Z. Mitogen- and stress-activated protein kinase 1 mediates activation of Akt by ultraviolet B irradiation. J. Biol. Chem. 276 (2001) 25558-25567
31. Ogden C.L., Flegal K.M., Carroll M.D., and Johnson C.L. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 288 (2002) 1728-1732
32. Osaki M., Kase S., Adachi K., Takeda A., Hashimoto K., and Ito H. Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45. J. Cancer Res. Clin. Oncol. 130 (2004) 8-14
33. Pang L., and Knox A.J. Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclooxygenase-2 in cultured human airway smooth muscle cells. Br. J. Pharmacol. 121 (1997) 579-587
34. Pentland A.P., Schoggins J.W., Scott G.A., Khan K.N., and Han R. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 20 (1999) 1939-1944
35. Romashkova J.A., and Makarov S.S. NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature 401 (1999) 86-90
36. Rose D.P., Komninou D., and Stephenson G.D. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes. Rev. 5 (2004) 153-165
37. Saleem M., Afaq F., Adhami V.M., and Mukhtar H. Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene 23 (2004) 5203-5214
38. Scott K.A., Moore R.J., Arnott C.H., East N., Thompson R.G., and Scallon B.J. An antitumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors. Mol. Cancer Ther. 2 (2003) 445-451
39. Sun Y., Tang X.M., Half E., Kuo M.T., and Sinicrope F.A. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res. 62 (2002) 6323-6328
40. Tron V.A., Rosenthal D., and Sauder D.N. Epidermal interleukin-1 is increased in cutaneous T-cell lymphoma. J. Invest. Dermatol. 90 (1988) 378-381
41. Tyrrell R.M. Activation of mammalian gene expression by the UV component of sunlight-from models to reality. BioEssays 18 (1996) 139-148
42. Werner H., and Le Roith D. New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia. Cell. Mol. Life Sci. 57 (2000) 932-942
43. Wilgus T.A., Koki A.T., Zweifel B.S., Kusewitt D.F., Rubal P.A., and Oberyszyn T.M. Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment. Mol. Carcinog. 38 (2003) 49-58
44. Williams C.S., Mann M., and DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18 (1999) 7908-7916
45. Wu Y., Cui K., Miyoshi K., Hennighausen L., Green J.E., and Setser J. Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors. Cancer Res. 63 (2003) 4384-4388